The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain)

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Oviedo, Manuel ^a,b   Muñoz, M Pilar ^b,c   Carmona, Gloria ^d   Borrás, Eva ^b,d   Batalla, Joan ^b,d   Soldevila, Nuria ^b   Domínguez, Angela ^b,e  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

GAM model; GLM model; Hepatitis B; Immigration; Incidence; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HEPATITIS B; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MIGRATION; PREVENTIVE HEALTH SERVICE; SPAIN; STATISTICAL MODEL; STATISTICS; VACCINATION;

ADOLESCENT; ADULT; CHILD; EMIGRATION AND IMMIGRATION; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; SPAIN; VACCINATION; YOUNG ADULT;

EID: 84864507033     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-614     Document Type: Article

References (34)

1. Hepatitis B immunization strategies: timing is everything. Mackie CO, Buxton JA, Tadwalkar S, Patrick DM, Can Med J A 2009 20 196 202
2. The global impact of vaccination against hepatitis B: A historical overview. Zanetti A, Van Damme P, Shouval D, Vaccine 2008 26 6266 6273 10.1016/j.vaccine.2008.09.056 18848855
3. Europes hepatitis challenge: defusing the viral bomb Piorkowsky NY, J Hepatol 2009 5 1068 1073
4. The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Levy AR, Kowdley KV, lloeje U, Taffese E, Mukherjee J, Gish R, Bzowej N, Briggs AH, Value in Health 2008 11 527 538 10.1111/j.1524-4733.2007.00297.x 18179664 (Pubitemid 351712982)
5. Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000). Beutels P, Heal Econ 2001 10 751 774 10.1002/hec.625 (Pubitemid 34041387)
6. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel M, Ward JW, MMWR 2008 57 RR08 1 20 19052530
7. World Health Organization, Viral hepatitis. Report by the Secretariat. Executive Board Geneva: WHO 2009
8. Prevalence of hepatitis B markers in the population of Catalonia (Spain) Rationale for universal vaccination of adolescents. Salleras L, Bruguera JM, Vidal J, Taberner JL, Plans P, Bayas JM, Pumarola T, Jimenez de Anta MT, Rodés J, Eur J Epidemiol 1992 8 5 640 644 10.1007/BF00145377 1426162
9. Hepatitis A and B in children and adolescents - what can we learn from Puglia (Italy) and Catalonia (Spain). Lopalco PL, Salleras L, Barbuti S, Germinario C, Bruguera M, Buti M, Domínguez A, Vaccine 2000 19 4-5 470- 474 10.1016/S0264-410X(00)00193-6 11027810
10. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Salleras L, Dominguez A, Bruguera M, Cardẽosa N, Batalla J, Carmona G, Navas E, Taberner JL, Vaccine 2005 23 2181 2184 10.1016/j.vaccine.2005.01.068 15755591 (Pubitemid 40341447)
11. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS, Int J Epidemiol 2005 34 1329 1339 10.1093/ije/dyi206 16249217 (Pubitemid 41819540)
12. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. La Torre G, Nicolotti N, de Waure C, Chiaradia G, Specchia ML, Mannocci A, Ricciardi W, Virol J 2008 5 84 10.1186/1743-422X-5-84 18652653
13. Childhood Hepatitis B Virus Infections in the United States Before Hepatitis B Immunization. Armstrong GL, Mast E, Wojczynski M, Margolis H, Pediatrics 2001 108 1123 1128 10.1542/peds.108.5.1123 11694691 (Pubitemid 33021186)
14. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy. Thornley S, Bullen C, Roberts M, J Theor Biol 2008 254 3 599 603 10.1016/j.jtbi.2008.06.022 18644385
15. Institut dEstadística de Catalunya (IDESCAT), Informaciá territorial: Banc destadístiques de municipis i comarques. Idescat 2007 http://www.idescat.net/cat/poblacio/poblestructura.html 22329287
16. Generalized linear models. Hastie TJ, Pregibon D, Chapter 6 of Statistical Models in S Boca Raton, FL: Chapman&Hall/CRC, Chambers JM, Hastie TJ, 1992 195 248
17. Venables WN, Ripley BD, Modern Applied Statistics with S New York: Springer 2002
18. Hastie TJ, Tibshirani RJ, Generalized additive models New York: Chapman and Hill 1990
19. A statistical model to estimate the impact of a hepatitis A vaccination programme. Oviedo M, Mũoz MP, Domínguez A, Borras E, Carmona G, Vaccine 2008 26 6157 6164 10.1016/j.vaccine.2008.08.066 18804511
20. Power Calculations for ZIP and ZIPNB. Williamson JM, Lin HM, Lyles RH, Hightower AW, J Data Sci 2007 5 519 534
21. Epidemiology of hepatitis B in the United States. Kim WR, Hepatology 2009 49 28 S34 10.1002/hep.22975 19399791
22. Centers for Disease Control and Prevention (CDC), Viral Hepatitis Surveillance - United States 2009 http://www.cdc.gov/hepatitis/statistics/ 2009surveillance/ 23115384
23. Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study. Raptopoulou M, Papatheodoridis G, Antoniou A, Ketikoglou J, Tzourmakliotis D, Vastiladis T, Manolaki N, Nikolopoulou G, Manesis E, Pierroutsakos I, J Viral Hepat 2009 16 195 202 10.1111/j.1365-2893.2008.01057.x 19175881
24. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. Buti M, Homs M, Rodriguez-Frias, Funalleras G, Jardí R, Sauleda S, Tabernero D, Schaper M, Esteban R, J Viral Hepat 2011 18 434 442 10.1111/j.1365-2893.2010.01324.x 20546496
25. Federal Ministry of the Interior, Migration and Integration. Residence law and policy on migration and integration in Germany (http://www.zuwanderung. de/EN/VeroeffDokumente/veroeffdokumente-node.html)
26. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Mast EE, Weunbaum EE, Fiore AE, Alter MJ, Bell BP, Finelly L, Rodewald LE, Douglas JM, Jansen RS, Ward JW, MMWR 2006 55 RR16 1 25 17183230
27. Recommended adult immunization schedule- United States, 2010. Centers for Disease Control and Prevention, MMWR 2010 59 1 4 21160459
28. American Academy of Pediatrics, 2009 Report of the Committee on Infectious Diseases Village, IL: American Academy of Pediatrics, Elk Grove, 28 2009 337 356
29. Census Bureau Homepage 2010 http://www.census.gov
30. Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: A seroepidemiological study. Baldo V, Floreani A, Menegon T, Grella P, Paternoster DM, Trivello R, Eur J Epidemiol 2000 16 87 91 10.1023/A:1007600532105 10780348 (Pubitemid 30186771)
31. Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination. Perz JF, Elm JL, Fiore AE, Huggler JI, Kuhnert WL, Effler PV, Pediatrics 2006 118 1403 1408 10.1542/peds.2006-0724 17015529 (Pubitemid 46393784)
32. Model based analysis of hepatitis B vaccination strategies in the Netherlands. Kretzschmar M, Mangen MJ, van de Laar M, de Wit A, Vaccine 2009 27 1254 1260 10.1016/j.vaccine.2008.12.009 19118594
33. Evaluation of mass vaccination programmes: the experience of hepatitis A in Catalonia. Oviedo M, Mũoz MP, Domínguez A, Carmona G, Batalla J, Borras E, Jansa JM, Rev Esp Salud Pública 2009 83 697 709 10.1590/S1135-57272009000500011
34. Geographical inequalities in health in New Zealand, 1980-2001. Paerce J, Dorling D, Int J Epidemiol 2006 35 597 603 10.1093/ije/dyl013 16455757 (Pubitemid 43985545)